Related Experiment Video

Updated: May 8, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.0K

General commentary: GQIcombi application to subdue glioma via differentiation therapy

BinBin Yuan1, Hui Gong2

  • 1Department of Public Relations, Affiliated Haimen Hospital of Xinglin College, Nantong University, Nantong, Jiangsu, China.

Frontiers in Oncology
|December 27, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
differentiation therapydrug resistancegliomasocial worktumor heterogeneity

More Related Videos

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.2K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.7K

Related Concept Videos